MedicaidCoverageMedium impact
Abrysvo (RSV Vaccine) for Pregnant Illinois Medicaid Customers and Arexvy (RSV Vaccine) Updates
Illinois Medicaid - HFS·IL · OB-GYN, Family Medicine, Pediatrics +1 more·Provider Notice
Effective date
Jan 31, 2024
We identified it
Jun 20, 2026
Summary
Illinois Medicaid ended coverage for Abrysvo RSV vaccine for pregnant patients (32-36 weeks) effective January 31, 2024. Monoclonal antibodies Beyfortus and Synagis remain covered through at least end of February 2024, and RSV vaccines for patients 60+ remain available without prior authorization.
Action Required
Immediately: Stop billing Illinois Medicaid for Abrysvo RSV vaccine for pregnant patients aged 32-36 weeks as coverage ended January 31, 2024. Continue billing for Beyfortus and Synagis monoclonal antibodies through February 2024. RSV vaccines for patients 60+ can continue to be billed without prior authorization through pharmacy or medical billing.